Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0NL2L
|
|||
Former ID |
DNC009725
|
|||
Drug Name |
3-[7'-(Methoxy)-napht-2'-yl]-quinuclidine-2-ene
|
|||
Synonyms |
CHEMBL478981; SCHEMBL2422138; KZWBNNXTWZPPPP-UHFFFAOYSA-N; BDBM50270302; 3-[7''-(Methoxy)-napht-2''-yl]-quinuclidine-2-ene; 3-(6-methoxy-2-naphthyl)-1-azabicyclo[2.2.2]oct-2-ene
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H19NO
|
|||
Canonical SMILES |
COC1=CC2=C(C=C1)C=C(C=C2)C3=CN4CCC3CC4
|
|||
InChI |
1S/C18H19NO/c1-20-17-5-4-14-10-16(3-2-15(14)11-17)18-12-19-8-6-13(18)7-9-19/h2-5,10-13H,6-9H2,1H3
|
|||
InChIKey |
KZWBNNXTWZPPPP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 894079-46-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Squalene synthetase (FDFT1) | Target Info | Inhibitor | [1] |
BioCyc | Cholesterol biosynthesis II (via 24,25-dihydrolanosterol) | |||
Cholesterol biosynthesis III (via desmosterol) | ||||
Cholesterol biosynthesis I | ||||
Superpathway of cholesterol biosynthesis | ||||
Epoxysqualene biosynthesis | ||||
KEGG Pathway | Steroid biosynthesis | |||
Metabolic pathways | ||||
Biosynthesis of antibiotics | ||||
Panther Pathway | Cholesterol biosynthesis | |||
Pathwhiz Pathway | Steroid Biosynthesis | |||
Reactome | Cholesterol biosynthesis | |||
PPARA activates gene expression | ||||
Activation of gene expression by SREBF (SREBP) | ||||
WikiPathways | Statin Pathway | |||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | ||||
Activation of Gene Expression by SREBP (SREBF) | ||||
SREBP signalling | ||||
Cholesterol Biosynthesis | ||||
Cholesterol biosynthesis |
References | Top | |||
---|---|---|---|---|
REF 1 | Quinuclidine derivatives as potential antiparasitics. Antimicrob Agents Chemother. 2007 Nov;51(11):4049-61. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.